QuantumScape Corporation, together with its subsidiaries, develops solid-state lithium-metal battery technology for electric vehicles and other applications in the United States.
FAIL · Does not pass the screen
4.03 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 18:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price4.03 USD at the 23 Oct 2026 close
Ethical screenDoes not pass
OptionsOpen interest leans heavily to calls (put/call 0.52)
Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 4.03 against the desk's fair-value range, base estimate 6.50, over the last year.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.52, read 2026-10-28
Ethical does not pass the values gate
Price4.03 USD
Fair value6.50
Ethical score70.0/100
Our investment reviews on this name
2026-09-10Read Markdown5.82-30.8% to today ✓Distribution gives way to Markdown after a 5% rise in 5 weeks
2026-08-09Read Distribution5.53-27.1% to today ✓Markup gives way to Distribution after a 22% slide in 5 weeks
2026-07-02Read Markup7.09-43.2% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
QuantumScape Corporation holds its Markdown at $4.03. The statistical read favours the sellers, held for 46 days.
As held on the ledger · 2026-10-23
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 46 days
Price at the screen
$4.03
Valuation
N/A trailing · -5.95 forward price to earnings
Values screen
FAIL· score 70.0
Beta
2.84
The Workings
Five Screens, Shown in Full
Does not pass. Interest-bearing securities
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
5.43%
Below 33%
Interest-bearing debt is just 5.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
56.59%
Below 33%
Interest-bearing cash and securities are 56.6% of assets, above the one-third limit.
Fail
Receivables
17.62%
Below 49%
Money owed to the company is 17.6% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
QuantumScape's business is fine, but its cash and interest-bearing securities are about 57% of its assets, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when QS's ethical verdict changes
Today QS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 61.3% margin of safety to the base estimate.
Third-party analyst targets: 8 covering, consensus Hold. The average target sits +61% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Battery dreams stall without real numbers
Picture an EV battery that promises to charge in minutes and last for a million miles, yet the company behind it still posts zero profit and a negative 38 percent return on equity. QuantumScape sits in exactly that spot, trading at 5.86 dollars against an analyst median of 8 dollars while showing a forward price to earnings ratio of negative 8.6 times. The ethical screen returns insufficient data because basic financial ratios are missing, so the opportunity rating stays at none.
We pass for straightforward reasons. No profits means the business model remains unproven at scale, and an unknown moat leaves investors guessing whether the solid-state technology can fend off bigger rivals already shipping cells today. The 39 percent gap to fair value looks attractive on paper, yet it rests on assumptions rather than cash flow or returns that actually exist.
Cyclical auto exposure adds another layer of uncertainty, with execution risk and funding needs likely to dominate until revenue appears. Currency swings or supply chain hiccups could widen losses further. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
QS trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Markdown$3.98+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter.
2026-10-21Markdown$3.98+1.3%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown$3.93+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markdown$3.93+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$3.93+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markdown$3.93+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markdown$3.93-14.2%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markdown$4.58+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markdown$4.58-0.2%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-11Markdown$4.59+0.0%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (8 analysts) rates it hold, with a mean price target of $7. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
